5AM Partners IV, LLC

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
5AM Partners IV, LLC, By /s/ Scott M. Rocklage, Managing Member
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for 5AM Partners IV, LLC

Form 4 holding 10%+ Owner

scPharmaceuticals Inc.

Security class
Common Stock
Shares / value
2,231,601
Estimated value
$14,259,930
Report date
10 Oct 2022
Price
$6.39
Ownership
By 5AM Ventures IV, L.P.
Form 4 holding 10%+ Owner

scPharmaceuticals Inc.

Security class
Common Stock
Shares / value
410,268
Estimated value
$2,621,613
Report date
10 Oct 2022
Price
$6.39
Ownership
By 5AM Opportunities I, L.P.
Form 4 holding 10%+ Owner

scPharmaceuticals Inc.

Security class
Common Stock
Shares / value
92,983
Estimated value
$594,161
Report date
10 Oct 2022
Price
$6.39
Ownership
By 5AM Co-Investors IV, L.P.
Form 4 holding 10%+ Owner

Pear Therapeutics, Inc.

Security class
Class A Common Stock
Shares / value
200,000
Estimated value
Report date
10 Apr 2023
Price
Ownership
By 5AM Opportunities I, L.P.
Form 4 holding 10%+ Owner

Pear Therapeutics, Inc.

Security class
Class A Common Stock
Shares / value
0
Estimated value
Report date
10 Apr 2023
Price
Ownership
By 5AM Co-Investors IV, L.P.
Form 4 holding 10%+ Owner

Pear Therapeutics, Inc.

Security class
Class A Common Stock
Shares / value
0
Estimated value
Report date
10 Apr 2023
Price
Ownership
By 5AM Ventures IV, L.P.

Insider Reports Filed by 5AM Partners IV, LLC

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .